# A Study on Using SFRT With Standard Treatment for Oligoprogressive NSCLC

> **NCT07193641** · PHASE2 · RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 25 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **RADIATION:** Spatially Fractionated Radiotherapy (SFRT)+Stereotactic Body Radiation Therapy (SBRT)
- **DRUG:** The systemic therapy

## Key facts

- **NCT ID:** NCT07193641
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-15
- **Primary completion:** 2027-06-15
- **Final completion:** 2028-06-15
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2025-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07193641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07193641, "A Study on Using SFRT With Standard Treatment for Oligoprogressive NSCLC". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07193641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*